Saltar al contenido

Publicaciones Año 2016

  • Álvarez-Calatayud G, Margolles A. 2016. Dual-coated lactic acid bacteria: an emerging innovative technology in the field of probiotics. Future Microbiology 11:467-475.
  • Arboleya S, Sánchez B, Solís G, Fernández N, Suárez M, Hernández-Barranco A, Milani C, Margolles A, de los Reyes-Gavilán CG, Ventura M, Gueimonde M. 2016. Impact of prematurity and perinatal antibiotics on the developing intestinal microbiota: a functional inference study. International Journal of Molecular Sciences 17:649 (14 páginas).
  • Blanco-Míguez, A.; Gutiérrez-Jácome, A.; Pérez-Pérez, M.; Pérez-Rodríguez, G.; Catalán-García, S.; Fernández-Riverola, F.; Lourenço, A.; Sánchez, B. 2016. From amino acid sequence to bioactivity: Scientific evidence on antitumor peptides. Protein Science 25:1084-1095.
  • Blanco-Míguez A, Meier-Kolthoff JP, Gutiérrez-Jácome A, Göker M, Fdez-Riverola F, Sánchez B, Lourenço A. 2016. Improving phylogeny reconstruction at the strain level using peptidome datasets. PLoS Comput Biol 12(12):e1005271.
  • Blanco-Míguez A, Gutiérrez-Jácome A, Fernández-Riverola F, Lourenço A, Sánchez B. 2016. A peptidome-based phylogeny pipeline reveals differential peptides at the strain level within Bifidobacterium animalis subsp. lactis. Food Microbiology 60:137-141.
  • Comino, I.; Bernardo, D.; Bancel, E.; Moreno, M.L.; Sánchez, B.; Barro, F.; Suligoj, T.; Ciclitira, P.; Cebolla, A.; Knight, S.; Branlard, G.; Sousa, C. 2016. Identification and molecular characterization of oat peptides implicated on coeliac immune response. Food and Nutrition Research 60:30324.
  • Cuervo, A.; Hevia, A.; López, P.; Suárez, A.; Díaz-Donado, C.; Sánchez, B.; Margolles, A.; González, S. 2016. Phenolic compounds from red wine and coffee are associated with specific intestinal microorganisms in allergic subjects. Food & Function 7:104-109.
  • Duranti S, Milani C, Lugli GA, Mancabelli L, Turroni F, Ferrario C, Mangifesta M, Viappiani A, Sánchez B, Margolles A, van Sinderen D, Ventura M. 2016. Evaluation of genetic diversity among strains of the human gut commensal Bifidobacterium adolescentis. Scientific Reports 6:23971 (10 páginas).
  • Ferrario, Ch.; Milani, Ch.; Mancabelli, L.; Lugli, G.A.; Duranti, S.; Mangifesta, M.; Viappiani, A.; Turroni, F.; Margolles, A.; Ruas-Madiedo, P.; van Sinderen, D.; Ventura, M. 2016. Modulation of the eps-ome transcription of bifidobacteria through simulation of human intestinal environment. FEMS Microbiology Ecology 92: fiw056.
  • Flórez AB, Sierra M, Ruas-Madiedo P, Mayo B. 2016. Susceptibility of lactic acid bacteria, bifidobacteria and other bacteria of intestinal origin to chemotherapeutic agents. International Journal of Antimicrobial Agents 48: 547–550.
  • Gutiérrez D, Hidalgo-Cantabrana C, Rodríguez A, García P, Ruas-Madiedo P. 2016. Monitoring in real time the formation and removal of biofilms from clinical related pathogens using an impedance-based technology. PLoS ONE 11(10): e0163966.
  • Gutiérrez-Díaz I, Fernández-Navarro T, Sánchez B, Margolles A, González S. 2016. Mediterranean diet and faecal microbiota: a transversal study. Food & Function 7:2347-2356
  • Hevia, A.; Milani, A.; López, P.; Cuervo, A.; Díaz, C.; Turroni, F.; González, S.; Suárez, A.; Gueimonde, M.; Ventura, M.; Sánchez, B.; Margolles, A. 2016. Allergic patients with long-term asthma display low levels of Bifidobacterium adolescentis. PLoS ONE 11:e0147809 (11 páginas).
  • Hidalgo-Cantabrana C, Algieri F, Rodriguez-Nogales A, Vezza T, Martínez-Camblor P, Margolles A, Ruas-Madiedo P, Gálvez J. 2016. Effectof a ropy exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strain orally administered on DSS-induced colitis mice model. Frontiers in Microbiology 7: article 868.
  • Linares, DM.; Del Rio, B.; Redruello, B.; Ladero, V.; Martin, MC.; Fernandez, M.; Ruas-Madiedo, P.; Alvarez, MA. 2016. Comparative analysis of the in vitro cytotoxicity of the dietary biogenic amines tyramine and histamine. Food Chemistry 197:658-663.
  • López P, de Paz B, Rodríguez-Carrio J, Hevia A, Sánchez B, Margolles A, Suarez A. 2016. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Scientific Reports 6:24072 (12 páginas).
  • López P, Sánchez B, Margolles A, Suarez A. 2016. Intestinal dysbiosis in SLE: cause or consequence? Current Opinion in Rheumatology 28:515-522.
  • Padilla B, Delgado S, García-Garrote F, Rodríguez JM, Romero B. 2016. Microbiological diagnosis of bacterial infection associated with delivery and postpartum. Enfermedades Infecciosas y Microbiología Clínica. 34:309-314.
  • Prior, P.; Ailloud, F.; Dalsing, B.; Remenant, B.; Sanchez, B.; Allen, C. 2016. Genomic and proteomic evidence supporting the division of the plant pathogen Ralstonia solanacearum into three species. BMC genomics 17:90.
  • Ríos-Covian D, Cuesta I, Alvarez-Buylla JR, Ruas-Madiedo P, Gueimonde M, de los Reyes-Gavilán CG. 2016. Bacteroides fragilis metabolices exopolysaccharides produced by bifidobacteria. BMC Microbiology 16:150 (8 pages).
  • Ríos-Covián, D.; Sánchez, B.; Cuesta, I.; Hernández-Barranco, A.; Gueimonde, M.; González De los Reyes-Gavilán, C. 2016. Glucolytic fingerprinting reveals metabolic groups within the genus Bifidobacterium: an exploratory study. Beneficial Microbes 7:265-273.
  • Rios-Covián, D.; Ruas-Madiedo, P.; Margolles, A.; Gueimonde, M.; de los Reyes-Gavilán, CG.; Salazar, N. 2016. Intestinal short chain fatty acids and their link with diet and human health. Frontiers in Microbiology 7:185.
  • Ruiz L, Hidalgo-Cantabrana C, Blanco-Míguez A, Lourenço A, Sánchez B, Margolles A. 2016. Tackling probiotic and gut microbiota functionality through proteomics. Journal of Proteomics 147:28-39.
  • Ruiz L, Delgado S, Ruas-Madiedo P, Margolles A, Sánchez B. 2016. Proteinaceous molecules mediating Bifidobacterium-host interactions. Frontiers in Microbiology 7: article 1193.
  • Salazar, N.; Gueimonde, M.; de los Reyes-Gavilán, C.G., Ruas-Madiedo, P. 2016. Exopolysaccharides produced by lactic acid bacteria and bifidobacteria as fermentable substrates by the intestinal microbiota. Critical Reviews in Food Science and Nutrition 56:1440-1453.
  • Serrano-Villar S, Rojo D, Martínez-Martínez M, Deusch S, Vázquez-Castellanos JF, Sainz T, Vera M, Moreno S, Estrada V, Gosalbes MJ, Latorre A, Margolles A, Seifert J, Barbas C, Moya A, Ferrer M. 2016. HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases. Scientific Reports 6:26192 (10 páginas).
  • Valdés-Varela, L.; Alonso-Guervos, M.; García-Suárez, O.; Gueimonde, M.; Ruas-Madiedo, P. 2016. Screening of bifidobacteria and lactobacilli able to antagonize the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer. Frontiers in Microbiology 7:577.
  • Valdés-Varela, L.; Hernández-Barranco, A.M.; Ruas-Madiedo, P.; Gueimonde, M. 2016. Effect of Bifidobacterium upon Clostridium difficile growth and toxicity when co-cultured in different prebiotic substrates. Frontiers in Microbiology 7:738.
  • Živkovic, M.; Miljkovic, MS; Ruas-Madiedo, P.; Markelic, MB.; Veljovic, K.; Tolinac, M.; Sokovic, S.; Korac, A.; Golic, N. 2016. EPS-SJ exopolisaccharide produced by the strain Lactobacillus paracasei subsp. paracasei BGSJ2-8 is involved in adhesion to epithelial intestinal cells and decrease on E. coli association to Caco-2 cells. Frontiers in Microbiology 7:286.


  • Alarcón T, D’Auria G, Delgado S, del Campo R, Ferrer M. 2016. Microbiota. Procedimientos en Microbiología Clínica Nº54. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC).
  • Delgado S, García-Garrote F, Padilla B,  Rodríguez JM, Romero B. 2016. Diagnóstico microbiológico de la infección bacteriana asociada al parto y puerperio. Procedimientos en Microbiología Clínica Nº59. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC).


  • Ruas-Madiedo, P. 2016. RedBAL. Revista |P|A|N| No. 2 pp. 59 (ISSN: 2445-3609).
    Sánchez B. 2016. Grupo de Investigación Funcionalidad y Ecología de Microorganismos Beneficiosos (MicroHealth) y EBT Microviable Therapeutics. Revista de la Asociación Asturiana de Enfermos de Colitis Ulcerosa y Enfermedad de Crohn. Nº74.
  • Margolles, A., Ruas-Madiedo, P., Sánchez, B., Delgado, S. 2016. Grupo “Funcionalidad y Ecología de Microorganismos beneficiosos” (MincroHealth). Revista SEM@foro. Especial Microbiología de los Alimentos. No. 62 pp. 43-44 (ISSN: 2254-4399)